Comparison of the Effectiveness of Topical 5-Fluorouracil, Topical Calcipotriol, and Liquid Nitrogen Cryosurgery in Seborrhoeic Keratosis
Downloads
Background: Seborrhoeic keratosis (SK) is a benign tumor composed of epidermal keratinocytes occurs most frequently in the elderly. The action of 5-fluorouracil (FU) cream and calcipotrienes on keratinocyte development and has been shown beneficial for SK. Purpose: To compare the effectiveness of 5-FU and calcipotriol topical with cryosurgery. Methods: Eighteen SK patients with 54 skin lesions were enlisted, which were separated into three groups. The first group received topical 5-FU twice daily, the second group received one 10-second freeze-thaw cycle of liquid nitrogen cryosurgery, and the third group received topical calcipotriol twice daily. The success of therapy was assessed based on the reduction in baseline lesion size, and observations were made every two weeks for three months. Result: This study found that at the 12th week, the mean percentage of decrease in lesion size in group I was 34.6%, group II was 100%, and group III was 6.18%. Statistically, there was a significant difference in the decrease in lesion size in groups treated with cryosurgery (p value<0.001). The most common side effect in group I was discomfort, whereas in group II it was hyperpigmentation. Patients from group III reported no negative effects. Conclusion: Topical 5-FU and topical calcipotriol are less effective than cryosurgery in SK in terms of reducing lesion size. However, topical 5-FU reduced the size of lesions more than topical calcipotriol.
Barthelmann S, Butsch F, Lang BM, Stege H, Großmann B, Schepler H, et al. Seborrheic keratosis. JDDG: J Dtsch Dermatol Ges. 2023(21):265-77.
Gorai S, Ahmad S, Raza SSM, Khan HD, Raza MA, Etaee F, et al. Update of pathophysiology and treatment options of seborrheic keratosis. Dermatol Ther. 2022;35(12):e15934.
Karadag A, Parish L. The status of the seborrheic keratosis. Clin Dermatol. 2018;36(2):275-7.
V Stoecker W, Kopel J, Geria N, Nosoudi N. Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses. J Drugs Dermatol. 2025;24(2):183-7.
Patel RT, Gay JJ, Fagan KK, Eikenberg JD. Non-psoriatic uses of calcipotriol: a concise updated review. Dermatol. Online J. 2023;29(3):1-19.
Natarelli N, Krenitsky A, Hennessy K, Moore S, Grichnik J. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review. J Dermatolog Treat. 2022;34(1):1-12.
Popadic S, Tomanovic M, Minic S. Effectiveness and safety of topical calcipotriol in the treatment of flat seborrheic keratosis on the face. Australas J Dermatol. 2023;64(2):e171-4.
Valek SA, Rashid RM, Rousseau MA, Rashid RM. Spiny keratoderma : A review of case reports and histopathological descriptions. J Cutan Pathol. 2023;50:371–7.
Chao YC, Ko MJ, Tsai WC, Hsu LY, Wu HY. Comparative efficacy of treatments for molluscum contagiosum: A systematic review and network meta-analysis. J Dtsch Dermatol Ges. 2023;21(6):587-597.
Luo W, Liang Y, Yang X, Wu W, Lu J. Histopathological Subtypes and Clinical Presentation of Seborrheic Keratosis: A 15-Year Retrospective Analysis of 1,169 Cases in Hainan, China. Clin Cosmet Investig Dermatol. 2025;18:721-727
Lahbacha B, Nechi S, Chaabane A, Bani A, Kchaou M, Chtourou F, et al. Seborrheic Keratosis: Report of a Rare Presentation and Reminder of the Current Knowledge of the Problem. Clin Pathol. 2024;17:1-6.
Heidenreich B, Denisova E, Rachakonda S, Sanmartin O, Dereani T, Hosen I, et al. Genetic alterations in seborrheic keratoses. Oncotarget. 2017;8(22):36639-49.
Nair PA, Bhavsar N, Patel D. Clinico-dermatoscopic study of seborrheic keratosis from a rural tertiary care centre of western India. Pigment International. Pigment Int. 2020;7(2):69-74.
Jackson J, Alexis A, Berman B, Berson D, Taylor S, Weiss J. Current understanding of seborrheic keratosis: prevalence, etiology, clinical presentation, diagnosis, and management. J Drugs Dermatol. 2015;14(10):1119-25.
Rosso JD. A closer look at seborrheic keratoses: patient perspectives, clinical relevance, medical necessity, and implications for management. J Clin Aesthet Dermatol. 2017;10(3):16-25.
Herron MD, Bowen AR, Krueger GG. Seborrheic keratoses: a study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimod. Int J Dermatol. 2004;43(4):300-2
Chalabi-Dchar M, Fenouil T, Machon C, Vincent A, Catez F, Marcel V, et al. A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate. NAR Cancer. 2021;3(3):1-13.
Alzahrani SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN. 5 Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncol Rep. 2023;50(4):1-16.
Azwar S, Seow HF, Abdullah M, Faisal Jabar M, Mohtarrudin N. Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment. Biology. 2021 10(9):1-34.
Singh R, McCain S, Feldman SR. Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis. JMIR Dermatol. 2023;6:1-9
Kurasaka C, Nishizawa N, Ogino Y, Sato A. Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil. ACS Omega. 2022;7(7):6046-52.
Maghfour J, Kuraitis D, Murina A. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review. J Drugs Dermatol. 2021;20(2):192-198.
Juntongjin P, Pongprasert R. Calcipotriol ointment shows comparable efficacy to topical steroids in chronic hand eczema. Dermatol Ther. 2019;32(4):e12956
Kazeminejad A, Bodaghi A, Hajheydari Z, Moosazadeh M, Rafati M, Gholizadeh N. Topical Calcipotriol for the Treatment of Cutaneous Warts: An Assessor-Blind Randomized Placebo-Controlled Trial. Dermatol Ther. 2023:e16666.
Voltan G, Cannito M, Ferrarese M, Ceccato F, Camozzi V. Vitamin D: An Overview of Gene Regulation, Ranging from Metabolism to Genomic Effects. Genes. 2023;14(9):1-16.
Maestro MA, Molnár F, Carlberg C. Vitamin D and Its Synthetic Analogs. J Med Chem. 2019;62(15):6854-75.
Dlott AH, Spencer SA, Di Pasqua AJ. Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article. Clin Drug Investig. 2024;44(10):733-7.
Gonzalez MCCC, Ramos VME, Ciriaco-tan CP. Topical Treatments for Seborrheic Keratosis: A Systematic Review. Acta Med Philipp. 2020;54(3):305–12.
Chughtai K, Gupta R, Upadhaya S, Al Hadidi S. Topical 5-Fluorouracil associated skin reaction. Oxf Med Case Reports. 2017;8:145-6.
Taylor S. Advancing the understanding of seborrheic keratosis. J Drugs Dermatol. 2017;16(5):419-24.
Aulia I, Wibawa LP, Suseno LS, Manikam NRM. Correlation Among Serum Calcidiol, Sun Index, and Vitamin D Intake in Individuals with Seborrheic Keratoses Living in Coastal Area Dermatol Pract Concept. 2024;14(2):e2024037.
Gurel M, Aral B. Effectiveness of erbium:YAG laser and cryosurgery in seborrheic keratoses: Randomized, prospective intraindividual comparison study. J Dermatolog Treat. 2015:1-4.
Kisis J, Zavorins A. Cryobiology and thermodynamics. In: P P, editor. Cryosurgery a practical manual. London: Springer; 2015. p. 19-32.
Copyright (c) 2025 Berkala Ilmu Kesehatan Kulit dan Kelamin

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.















